门冬氨酸钾镁注射液对急性心梗室性心律失常的疗效

The Effect of Potassium Magnesium Aspartate Injection on Ventricular Arrhythmia in Acute Myocardial Infarction

目的研究门冬氨酸钾镁注射液联合盐酸胺碘酮注射液治疗急性心肌梗死室性心律失常的临床应用价值与效果分析。方法选取急性心肌梗死室性心律失常患者90例作为研究对象。将所有患者随机分为观察组和对照组。对照组采用盐酸胺碘酮注射液治疗,而观察组采用门冬氨酸钾镁注射液联合盐酸胺碘酮注射液治疗。治疗后,对两组患者的治疗效果和心功能相关参数进行比较分析。结果治疗后,观察组患者的治疗有效率高于对照组,差异具有统计学意义(P <0.05)。治疗后,观察组的SV、LVEF、LVFS、LVD水平均高于对照组,LVS水平低于对照组,组间数据比较,差异具有统计学意义(P <0.05)。结论门冬氨酸钾镁注射液联合盐酸胺碘酮注射液治疗在急性心肌梗死室性心律失常的临床治疗效果显著。

Objective To study the clinical application value and effect of potassium magnesium aspartate injection combined with amiodarone hydrochloride injection in the treatment of ventricular arrhythmia in acute myocardial infarction. Methods 90 patients with ventricular arrhythmia in acute myocardial infarction were selected as the study subjects. All patients were randomly divided into observation group and control group. The control group was treated with amiodarone. The observation group was treated with potassium magnesium aspartate combined with amiodarone. After treatment, the therapeutic effect and cardiac function parameters of the two groups were compared and analyzed. Results After treatment, the effective rate of the observation group was higher than that of the control group, with statistical significance (P < 0.05). After treatment, the levels of SV, LVEF, LVFS and LVD in the observation group were higher than those in the control group, and the level of LVS was lower than that in the control group. There was a significant difference between the two groups (P < 0.05). Conclusion The clinical effect of potassium magnesium aspartate injection combined with amiodarone hydrochloride injection on ventricular arrhythmia in acute myocardial infarction is remarkable.